Skip to content
GLP-1 Scorecard
Menu
Graded #46

Henry Meds

A flat-fee compounded pioneer — simple, but priced at the higher end of the board now.

Visit Henry MedsWe may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
$249/mo
Tirzepatide
$349/mo
Coverage
Multi-state
Brand-name
Compounded only

Weigh Henry Meds against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. Because Henry Meds dispenses compounded medication, it’s worth understanding whether compounded semaglutide is legit and safe.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value72/100
Dose & formulation80/100
Clinical oversight80/100
Labs & monitoring78/100
Fulfillment78/100
Contract terms78/100

Strengths

  • Simple flat-fee model
  • Established brand
  • Both molecules

Where it loses points

  • Higher pricing than newer entrants
  • Compounded only

Bottom line — Grade C+

Best for: People who want a simple, well-known flat-fee program.

Ranked #46 of 508 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

Closest on the board

The boards grading nearest Henry Meds — the realistic shortlist.

The 20 boards nearest this one

View full scorecard rankings →

Pricing/verification reflect Henry Meds's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Henry Meds's site. Not medical advice; see our disclosure.

← Back to the scorecard